Spotlight
Video

Udai Banerji,et al: Results of two Phase 1 multicenter trials of AZD5363, an inhibitor of AKT1,2, 3

feeds has 409 videos Subscribe Here

Loading........
Description: AACR 2013 Pressconference April 7: Treatment and Resistance to Targeted Therapies
Udai Banerji,et al: Results of two Phase 1 multicenter trials of AZD5363, an inhibitor of AKT1, 2 and 3: biomarker and early clinical evaluation in Western and Japanese patients with advanced solid tumors
Shared By : feeds
Posted on : 04/10/13
Added : 5 years ago
Category : General



More From feeds

Nothing found.